Dr. Robert Michael Levy is a Scottsdale, Arizona based male rheumatologist who is specialized in Rheumatology. Active license number of Dr. Robert Michael Levy for Rheumatology is 32295 in Arizona. Dr. Robert Michael Levy treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. Robert Michael Levy speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
M.D.
Gender:
Male
Practice Address:
4725 N Scottsdale Rd, Suite 200, Scottsdale, Arizona, 85251-7620
Phone:
480-483-1410
Fax:
480-483-2604
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1922208644
NPI Enumeration Date:
20 Jul, 2007
NPI Last Update On:
07 Mar, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Robert Michael Levy are as mentioned below.
License Number
Specialization
State
Status
32295
Rheumatologist
Arizona
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3787 E Villa Cassandra Way, Cave Creek, Arizona
Zip:
85331-9514
Phone Number:
480-483-6779
Fax Number:
--
Patients can reach Dr. Robert Michael Levy at 4725 N Scottsdale Rd, Suite 200, Scottsdale, Arizona or can call to book an appointment on 480-483-1410. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.